While myelin-reactive T cells are the key cells releasing chemicals and causing inflammation in the MS lesions, T cells were also shown to target OPCs and inhibit remyelination as well as CD8+ T cell infiltration into the CNS via the IFNγ-mediated promotion of antigen cross-presentation in the cuprizone-induced demyelination model [90]. Here, IFNG is linked to myeloid sarcoma.